Related Experiment Video
Updated: Aug 2, 2026

09:11
Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
Published on: April 9, 2019
21.4K
Predicting clinically significant prostate cancer in elderly patients: A nomogram approach with shear wave
Xiang Liu1, Jia Zhu1, Meng-Qi Shi2
1Department of Ultrasound, The Second Affiliated Hospital of Nantong University, Nantong, China.
The Prostate
|September 12, 2024
Summary
A new nomogram using shear wave elastography (SWE) effectively detects clinically significant prostate cancer (csPCa) in elderly men. This tool reduces unnecessary biopsies by accurately identifying csPCa, improving diagnostic decisions.
Area of Science:
- Urology
- Medical Imaging
- Oncology
Background:
- Prostate cancer (PCa) diagnosis in elderly men often relies on invasive biopsies.
- Accurate detection of clinically significant prostate cancer (csPCa) is crucial for appropriate treatment.
- Shear wave elastography (SWE) offers a non-invasive method to assess tissue stiffness, potentially aiding PCa detection.
Purpose of the Study:
- To develop and validate a nomogram incorporating SWE parameters for detecting csPCa in elderly individuals.
- To assess the diagnostic performance and clinical utility of the developed nomogram.
Main Methods:
- A cohort of 290 elderly men with suspected PCa underwent prostate biopsy and SWE imaging.
- The LASSO algorithm and logistic regression were used to build the nomogram, including features like Emean, ΔEmean, prostate volume, prostate-specific antigen density (PSAD), and transrectal ultrasound (TRUS).
- Receiver operating characteristic (ROC) curves, calibration curves, decision curves, and clinical impact curves were used for validation and assessment of clinical usefulness.
Main Results:
- The nomogram demonstrated strong discriminatory ability with an AUC of 0.89 (95% CI: 0.83-0.94), outperforming a clinical model without SWE parameters.
- The nomogram achieved an accuracy of 0.83, sensitivity of 0.89, and specificity of 0.78.
- Utilizing a 20% probability threshold, the nomogram reduced biopsies by 25% without missing any csPCa cases, showing improved clinical impact.
Conclusions:
- The developed nomogram effectively identifies elderly men with csPCa.
- This tool aids in informed clinical decision-making by providing accurate diagnostic outcomes.
- The nomogram offers significant clinical benefits by reducing unnecessary biopsies and improving diagnostic accuracy.

